About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Simvastatin-Ezetimibe Combination of No Use in Slowing Artery Disease Progress

by Rajashri on July 22, 2008 at 4:15 PM
 Simvastatin-Ezetimibe Combination of No Use in Slowing Artery Disease Progress

In a huge setback a study has found that the Simvastatin-Ezetimibe reduces risk of coronary artery disease (CAD), but does not slow its progression.

The Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study was designed to examine the effects of lowering low-density lipoprotein (LDL) cholesterol in patients with aortic stenosis and involved 1,873 patients with mild to moderate aortic stenosis

Advertisement

All patients were assigned to randomly receive simvastatin 40 mg QD and ezetimibe 10 mg QD or equivalent dose of placebo.

The combination therapy was found to lower LDL or bad cholesterol and thus reduce risk of CAD, but it was not able to slow down the progression of the disease.

Source: Medindia
RAS/L
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Drug News

Projected Growth: Psychedelic Drug Market Anticipated to Hit $7.2 Billion by 2029
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
Promising ALS Drug Candidate Extends Lifespan
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-Calvulanate Vs Amoxicillin Preference in Child Sinusitis Treatment
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
ADHD Medication Errors Surge by Nearly 300%
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
Unknown Medication Side Effects Reported by 52% of Indian Families
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Simvastatin-Ezetimibe Combination of No Use in Slowing Artery Disease Progress Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests